Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma.
about
Deficient mismatch repair: Read all about it (Review)Toward a Molecular Classification of Colorectal Cancer: The Role of BRAFBRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer.Detection of the BRAF V600E mutation in colon carcinoma: critical evaluation of the imunohistochemical approachA further investigation of combined mismatch repair and BRAFV600E mutation specific immunohistochemistry as a predictor of overall survival in colorectal carcinomaBRAF V600E immunohistochemistry is reliable in primary and metastatic colorectal carcinoma regardless of treatment status and shows high intratumoral homogeneityImmunohistochemistry with the anti-BRAF V600E (VE1) antibody: impact of pre-analytical conditions and concordance with DNA sequencing in colorectal and papillary thyroid carcinoma.Performance comparison of three BRAF V600E detection methods in malignant melanoma and colorectal cancer specimens.A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer.Immunohistochemical detection of the BRAF V600E mutant protein in colorectal neoplasmsA model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients.Annexin A10 expression in colorectal cancers with emphasis on the serrated neoplasia pathwayConcomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumorsDielectrophoresis for Biomedical Sciences Applications: A Review.Diagnostic Accuracy of BRAF Immunohistochemistry in Colorectal Cancer: a Meta-Analysis and Diagnostic Test Accuracy Review.Molecular Diagnostic Applications in Colorectal Cancer.Immunohistochemical detection of the BRAF V600E mutation in melanoma patients with monoclonal antibody VE1.Detection of BRAF mutation in Chinese tumor patients using a highly sensitive antibody immunohistochemistry assay.BRAF V600E mutations are characteristic for papillary craniopharyngioma and may coexist with CTNNB1-mutated adamantinomatous craniopharyngioma.BRAF mutation in sporadic colorectal cancer and Lynch syndrome.Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review.Immunohistochemical detection of the BRAF V600E mutant protein in colorectal cancers in Taiwan is highly concordant with the molecular test.The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis.Utility of BRAF V600E mutation-specific immunohistochemistry in detecting BRAF V600E-mutated gastrointestinal stromal tumors.Immunohistochemical Detection of NRASQ61R Mutation in Diverse Tumor Types.Immunohistochemical staining for p16 and BRAFV600E is useful to distinguish between sporadic and hereditary (Lynch syndrome-related) microsatellite instable colorectal carcinomas.Invasion pattern and histologic features of tumor aggressiveness correlate with MMR protein expression, but are independent of activating KRAS and BRAF mutations in CRC.Immunohistochemistry as a quick screening method for clinical detection of BRAF(V600E) mutation in melanoma patients.Ultra-deep sequencing confirms immunohistochemistry as a highly sensitive and specific method for detecting BRAF V600E mutations in colorectal carcinoma.Utility of BRAF VE1 Immunohistochemistry as a Screening Tool for Colorectal Cancer Harboring BRAF V600E Mutation.A cautionary note on the immunohistochemical detection of BRAF v600e mutations in serrated lesions of the colon.Evaluation of allele-specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia.
P2860
Q26796491-8CB07712-0B92-4AA1-B570-C1A2249F45C7Q26827212-06A68873-FF9A-489A-9379-1B65538822AFQ33615076-14484309-44CE-4F2D-89C0-D1786ED3D748Q34052740-C543D0FC-CF7A-46E8-8107-DB6FFFAB9121Q34084086-03B52035-0A25-4B9C-8A31-65F95F2702D5Q34206112-54107BB7-F5EF-449C-91BB-D6EAB05A8B96Q34520869-883CDB33-2F6F-42DF-A73C-C6ED89E89E7EQ35126758-B72983E2-8462-49A1-A943-963B795C4E5DQ35187723-3D23279D-553C-476F-8AE6-A45F537034B7Q35527097-B40481B2-1ACC-4540-BADC-C5C7266155ECQ35596050-C6FE779A-04AD-4760-81A1-D09D0FCD7E18Q36037920-F0DE00CA-97CA-44EC-8F14-361AE72F4993Q37327430-C993DE44-619B-4D05-BB8E-80D3DE599786Q37732473-7595C37D-DEEB-4BB6-97EF-BECA3B11ED35Q38838631-7451D7DA-8F31-45F5-83CD-B97FD9B6331DQ38947671-B97A6E8F-CEB1-483D-B488-73423324EEEDQ39105498-CEFC75BA-58A3-42F9-88FE-688E3808FE77Q41857360-F856E950-DD3B-4756-A7B2-A7434A96A128Q42576098-EADC785A-0860-4426-B98E-56485F4C1CE1Q43688934-DB84C297-1756-4184-9450-841FD762CBF1Q47614611-480BBD94-D33A-4654-B39D-C5326D5D0DFCQ48070124-EC51B864-2CCF-476D-8187-8FE4E65058FDQ48217203-916A459E-DFC8-4C74-A9AE-9B773632CBFCQ52908238-57130D12-7F4A-40A0-B2AE-6FA226E8AA43Q53227877-B24544D4-585F-4F02-8960-A6355A682926Q54193016-FB2AC4A2-1EDE-49F8-885A-3F83C5682ACCQ54345735-6343A055-5233-466D-B2F2-FFB958051BFEQ54375442-7385C2FE-5242-4639-8BAA-E30A11A4CA60Q54405775-55562108-96F2-4EB0-88C2-931F53F593BFQ55015727-BF724B67-E245-468B-A67C-DF6A3407DF13Q55060158-2FD4DF32-5821-48A0-AE88-399EC158A820Q55069257-81B0129A-130A-48AB-AEF8-27B8C4CE0224
P2860
Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Immunohistochemistry using the ...... in colorectal adenocarcinoma.
@en
Immunohistochemistry using the ...... in colorectal adenocarcinoma.
@nl
type
label
Immunohistochemistry using the ...... in colorectal adenocarcinoma.
@en
Immunohistochemistry using the ...... in colorectal adenocarcinoma.
@nl
prefLabel
Immunohistochemistry using the ...... in colorectal adenocarcinoma.
@en
Immunohistochemistry using the ...... in colorectal adenocarcinoma.
@nl
P2093
P2860
P921
P356
P1433
P1476
Immunohistochemistry using the ...... in colorectal adenocarcinoma.
@en
P2093
Cheryl A Adackapara
Justine A Barletta
Lynette M Sholl
P2860
P304
P356
10.1111/HIS.12154
P577
2013-06-13T00:00:00Z